In summary, for pregnant patients who received Membrane Sweeping at Term to Induce Labor

Benefits in NNT

  • 12.5% of patients were helped (spontaneous onset of labor) compared with expectant management
  • 8.3% of patients were helped (avoided further induction techniques) compared with expectant management
  • 1 in 8 patients was helped (spontaneous onset of labor) compared with expectant management
  • 1 in 12 patients was helped (avoided further induction techniques) compared with expectant management

Harms in NNT

    No one was harmed
    No one was harmed (no change in the rate of unassisted vaginal delivery)

View As:

Source: Ford B, Anderson A, Nichols C. Membrane sweeping at term to induce labor. afp. 2022;106(1):21A-21B.

Study Population: Patients who are pregnant with a live fetus at or near term (36 weeks or greater estimated gestational age) without indication for induction or urgent delivery

Efficacy Endpoints: Primary: spontaneous onset of labor, need for induction of labor, need for cesarean delivery, spontaneous vaginal delivery; secondary: instrument-assisted vaginal birth, epidural analgesia

Harm Endpoints: Primary: maternal death or serious morbidity, uterine hyperstimulation with or without fetal heart rate deceleration, neonatal death, serious perinatal morbidity; secondary: postpartum hemorrhage, uterine rupture, augmentation of labor

Narrative: Approximately 20% to 25% of deliveries occur after labor induction in middle-to high-income countries.1 Membrane sweeping is a common outpatient intervention associated with cervical dilatation assessment. Membrane sweeping is the advancement of one or two fingers through the internal cervical os to the lower uterine segment, followed by a circular sweeping movement between the amniotic membrane and the lower uterine segment. Successful performance of this procedure can decrease the need for formal induction with pharmacologic or mechanical methods or the need for hospitalization or advanced monitoring. The process of membrane sweeping leads to the release of phospholipase A2 and prostaglandin F, which directly contribute to cervical ripening through an inflammatory cascade.2

A 2020 Cochrane review included 44 studies and 6,940 patients in 19 countries (14 from the United States).2 The trials compared membrane sweeping with expectant management, sham membrane sweeps, and several induction methods, including vaginal and intracervical prostaglandins and intravenous oxytocin (Pitocin). Seventeen randomized controlled trials (RCTs) with 3,170 patients compared membrane sweeping with expectant management, demonstrating a relative risk of 1.21 (95% CI, 1.08 to 1.34), an absolute risk difference of 12.5%, and a number needed to treat of 8 for spontaneous onset of labor. Sixteen RCTs with 3,224 patients demonstrated a relative risk of 0.73 (95% CI, 0.56 to 0.94) for requiring labor induction. This corresponds to an absolute risk reduction of 8.5% and a number needed to treat of 12 to prevent the need for further mechanical or pharmacologic induction of labor. Other primary outcomes, including the likelihood of spontaneous vaginal delivery, were not significantly different.

Evidence certainty was low to moderate for all primary outcomes. Patient perception of membrane sweeping was positive. In one study in the Netherlands (n = 742), 88% of patients noted they would opt for membrane sweeping in subsequent pregnancies if it were offered; 31% characterized the procedure as not painful, 51% as somewhat painful, and 17% as painful or very painful. Even among those who had pain, 88% indicated they would opt for the procedure again.3

Caveats: Despite the good numbers needed to treat and large sample sizes, the studies included in the Cochrane review had low certainty of evidence as assessed using the GRADE approach. The authors performed sensitivity analyses and excluded studies at high or unclear risk of bias for sequence generation or allocation concealment and studies with high or unclear risk of attrition. When sensitivity analyses were performed, including 12 of the 40 identified trials with low risk of bias, the result for spontaneous onset of labor was no longer statistically significant. Moderate heterogeneity was present in these included trials (Tau2 = 0.00; I2 = 37%; P = .16).

This Cochrane review predates the ARRIVE trial, which examined the safety of induction vs. expectant management at 39 weeks’ estimated gestational age. The results of ARRIVE are expected to increase the overall percentage of induced deliveries.4, 5, 6, 7 Therefore, a safe, evidence-based modality such as membrane sweeping, which minimizes the need for formal induction, could have strong clinical utility.

The Cochrane review included data from 19 countries, a breadth of resource settings, and urban and rural locations. There was significant procedural heterogeneity across studies in the number of revolutions and standard depth of digital advancement in the membrane sweeping procedure. Sweeps can also be associated with bleeding from undiagnosed placenta previa or a low-lying placenta, which were not reported in this review because they were exclusion criteria.

There are concerns about the safety of membrane sweeping in carriers of group B streptococci. A prospective trial of 542 patients who underwent membrane sweeping demonstrated a nonsignificant difference in all study outcomes between those who were positive for group B streptococci and those who were negative.8

This Cochrane review did not address the possibility of artificial rupture of membranes after membrane sweeping. In one RCT of 300 patients, there was no significant difference in rates of prelabor rupture of membranes when directly comparing those who underwent membrane sweeping with those who did not. In subgroup analyses, patients with cervical dilatation of 1 cm or greater had a relative risk of 1.10 (95% CI, 1.03 to 1.18), with a number needed to harm of 378 for prelabor rupture of membranes.9 Studies comparing membrane sweeping with amniotomy and oxytocin demonstrated no statistically significant differences in outcomes or safety across the study groups. The same was true of one-time membrane sweeping vs. recurrent membrane sweeping.2

The original manuscript was published in Medicine by the Numbers, American Family Physician as part of the partnership between and AFP.

Author: Brian Ford, MD, FAAFP; Andrew Anderson, MD; Carrie Nichols, MD
Supervising Editors: Shahriar Zehtabchi, MD

Published/Updated: August 4, 2022

  1. The Title Bar

    The title bar is color-coded with our overall recommendation.

    • Green: Benefits outweigh risks.
    • Yellow: Unclear risk/benefit profile.
    • Red: Benefits do not outweigh risks.
    • Black: Obvious harms, no clear benefits.
  2. Tip content...